Concepedia

Daniel F. Tardiff

DF

Statistics

Publications

19

Citations

2K

H-Index

17

Active since

2004

Affiliations

Howard Hughes Medical Institute(Current)

Whitehead Institute for Biomedical Research

Harvard University

Massachusetts Institute of Technology

Brandeis University

Daniel F. Tardiff is an author at Howard Hughes Medical Institute specializing in life sciences, neuroscience, and neurodegenerative diseases.

ORCID

Publications per year

2004–2023

19

Publications

19

Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons

Chee Yeun Chung, Vikram Khurana, Pavan K. Auluck et al. · Science · 2013 · 461 citations · Full text

, , +17

Yeast Reveal a “Druggable” Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons

Daniel F. Tardiff, Nathan T. Jui, Vikram Khurana et al. · Science · 2013 · 258 citations · Full text

, , +17

Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models

Linhui Julie Su, Pavan K. Auluck, Tiago F. Outeiro et al. · Disease Models & Mechanisms · 2009 · 176 citations · Full text

, , +17

Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity

Kent Matlack, Daniel F. Tardiff, Priyanka Narayan et al. · Proceedings of the National Academy of Sciences · 2014 · 166 citations · Full text

, , +17

Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity

Benjamin Vincent, Daniel F. Tardiff, Jeff S. Piotrowski et al. · Cell Reports · 2018 · 135 citations · Full text

, , +17

1–5 of 19